Roche gets CDSCO Panel nod to import, market ophthalmic drug Faricimab solution Dr. Divya Colin6 March 2023 6:00 PM ISTNew Delhi: Granting the request for waiver of Phase III clinical trial of Faricimab 6mg/0.05mL solution for Intravitreal Injection in the country, the...
Intravitreal Faricimab improves visual and anatomic outcomes for Aflibercept-Resistant nAMD Dr Ishan Kataria2 Jan 2023 9:45 AM ISTIntravitreal therapies neutralizing vascular endothelial growth factor (VEGF) have considerably reduced the extent of vision loss in patients with...
Roche Gets CDSCO Panel Nod To study Ophthalmic Drug Faricimab Dr. Divya Colin3 Dec 2022 5:30 PM ISTNew Delhi: Suggesting that the protocol title and phase should be revised for India, the Subject Expert Committee (SEC) functional under the Central...
BALATON, COMINO phase III studies of Vabysmo for people with retinal vein occlusion meet primary endpoints: Roche Ruchika Sharma30 Oct 2022 4:30 PM ISTBasel: Roche has announced positive topline results from two global phase III studies, BALATON and COMINO, evaluating the first and only bispecific...
Roche gets European Commission approval for Vision loss drug Vabysmo Ruchika Sharma20 Sept 2022 12:45 PM ISTBasel: Roche has announced that the European Commission (EC) has approved Vabysmo (faricimab) for the treatment of neovascular or 'wet' age-related...
Faricimab reduces treatment burden of neovascular age-related macular degeneration: Lancet Jacinthlyn Sylvia20 July 2022 8:00 PM ISTA new study published in The Lancet suggests that Faricimab can effectively prolong the duration between treatments with continued efficacy and reduce...
Intravitreal faricimab improves vision and retinal anatomy in diabetic macular edema cases: Lancet Medical Dialogues Editorial Team7 Feb 2022 9:00 AM ISTUSA: A team of researchers led by Charles C Wykoff conducted a study that showed that with flexible dosage up to every 16 weeks, faricimab showed...
